Suchen Sie nach Informationen zu Hauptsitz Von Abraxis Bioscience? Folgen Sie den Links unten, um alle Informationen zu finden, die Sie benötigen, und mehr.
https://en.wikipedia.org/wiki/Abraxis_BioScience
https://www.dnb.com/business-directory/company-profiles.abraxis_bioscience_llc.8ebdf4634e3266d05a7e12db887dfa7a.html
Find company research, competitor information, contact details & financial data for Abraxis Bioscience, LLC of Phoenix, AZ. Get the latest business insights from Dun & Bradstreet.
https://www.crunchbase.com/organization/abraxis-bioscience
Phone Number 310-883-1300. Abraxis BioScience, Inc., a biotechnology company, engages in the discovery, development, and delivery of next-generation therapeutics and core technologies that offer treatments for cancer and other critical illnesses. The company principally offers Abraxane, a nanoparticle chemotherapeutic compound that is based on its proprietary tumor.
https://www.dnb.com/business-directory/company-profiles.abraxis_bioscience_llc.4882ef513d32d80c75a6dc9a3693b15e.html
Find company research, competitor information, contact details & financial data for Abraxis Bioscience, LLC of Los Angeles, CA. Get the latest business insights from Dun & Bradstreet. D&B Business Directory HOME / BUSINESS DIRECTORY / MANUFACTURING / CHEMICAL MANUFACTURING / PHARMACEUTICAL AND MEDICINE MANUFACTURING
https://www.zoominfo.com/c/abraxis-bioscience-llc/353573377
Who is Abraxis BioScience. ABRAXANE uses albumin, a human protein, to deliver the chemotherapy. It does not contain chemical solvents, like Cremophor. This eliminates the need for premedication with steroids or antihistamines for hypersensitivity reactions caused by these solvents. Plus, sin Read More.
https://ch.linkedin.com/company/abraxis-bioscience
Abraxis BioScience | 2.867 Follower auf LinkedIn Abraxis BioScience is a fully integrated biotechnology company dedicated to delivering progressive therapeutics, such as ABRAXANE, and core technologies that offer patients and medical professionals safer and more effective treatments for cancer and other critical illnesses. Abraxis' portfolio includes the world's first …
https://pitchbook.com/profiles/company/42098-68
Description. Provider of bio-medical services for cancer and other critical illnesses. The company is engaged in the discovery, development and delivery of next-generation therapeutics and core technologies that offer patients different types of treatments. It offers a nanoparticle chemotherapeutic compound that is based on its proprietary tumor targeting nab technology …
https://www.marketscreener.com/quote/stock/ABRAXIS-BIOSCIENCE-INC-66748/company/
abraxis bioscience, inc. Add to my list End-of-day quote Nasdaq - 05/30 12:34:46 pm EDT
https://www.bloomberg.com/profile/company/0196850D:US
Company profile page for Abraxis BioScience LLC including stock price, company news, press releases, executives, board members, and contact information
https://www.marketscreener.com/quote/stock/ABRAXIS-BIOSCIENCE-INC-66748/
End-of-day quote Nasdaq - 03:19 2022-07-20 pm EDT. -. USD. 0.00%. 2010. ABRAXIS BIOSCIENCE : Celgene and Abraxis Announce Shareholder Vote in Favor of Merger. BU. 2010. ABRAXIS BIOSCIENCE : and Specialised Therapeutics Announce Approval to Market ABRAXANE for Metastatic Breast Cancer in New Zealand.
Wir hoffen, dass Sie über die obigen Links alle notwendigen Informationen zu Hauptsitz Von Abraxis Bioscience gefunden haben.
